KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Charles River Laboratories International (CRL) Net Margin (2016 - 2025)

Historic Net Margin for Charles River Laboratories International (CRL) over the last 16 years, with Q3 2025 value amounting to 5.42%.

  • Charles River Laboratories International's Net Margin fell 13900.0% to 5.42% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.07%, marking a year-over-year decrease of 122500.0%. This contributed to the annual value of 0.25% for FY2024, which is 112400.0% down from last year.
  • Latest data reveals that Charles River Laboratories International reported Net Margin of 5.42% as of Q3 2025, which was down 13900.0% from 5.07% recorded in Q2 2025.
  • In the past 5 years, Charles River Laboratories International's Net Margin ranged from a high of 18.46% in Q4 2023 and a low of 21.52% during Q4 2024
  • For the 5-year period, Charles River Laboratories International's Net Margin averaged around 8.08%, with its median value being 9.15% (2023).
  • As far as peak fluctuations go, Charles River Laboratories International's Net Margin surged by 26700bps in 2022, and later tumbled by -399700bps in 2024.
  • Over the past 5 years, Charles River Laboratories International's Net Margin (Quarter) stood at 15.45% in 2021, then increased by 11bps to 17.19% in 2022, then grew by 7bps to 18.46% in 2023, then tumbled by -217bps to 21.52% in 2024, then surged by 125bps to 5.42% in 2025.
  • Its last three reported values are 5.42% in Q3 2025, 5.07% for Q2 2025, and 2.59% during Q1 2025.